Atovaquone and azithromycin treatment for babesiosis in an infant

Pediatric Infectious Disease Journal

Volumn 26, Issue 2, 2007, Pages 181-183

  Raju, Mina ^a   Salazar, Juan C ^b,c   Leopold, Harris ^b   Krause, Peter J ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c Farmington   (United States)

Author keywords

Atovaquone; Azithromycin; Babesiosis; Child

Indexed keywords

AMOXICILLIN; ATOVAQUONE; AZITHROMYCIN; CLINDAMYCIN; QUININE;

ACUTE OTITIS MEDIA; ANEMIA; ARTICLE; BABESIA MICROTI; BABESIOSIS; BLALOCK TAUSSIG ANASTOMOSIS; BLOOD SMEAR; BLOOD TRANSFUSION; CASE REPORT; COMBINATION CHEMOTHERAPY; CYANOTIC HEART DISEASE; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLENN SHUNT; HEART SURGERY; HUMAN; INFANT; LYME DISEASE; PAPULAR RASH; PARASITE IDENTIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; THROMBOCYTOPENIA;

ANIMALS; ANTIGENS, PROTOZOAN; ANTIPROTOZOAL AGENTS; ATOVAQUONE; AZITHROMYCIN; BABESIA MICROTI; BABESIOSIS; BLOOD TRANSFUSION; CYANOSIS; DNA, PROTOZOAN; ERYTHROCYTES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HEART DISEASES; HUMANS; INFANT; POLYMERASE CHAIN REACTION;

EID: 33846568398     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000250622.11505.8f     Document Type: Article

References (16)

1. Wittner M, Rowin KS, Tanowitz HB, et al. Successful chemotherapy of transfusion babesiosis. Ann Intern Med. 1982;96:601-604.
2. Krause PJ, Lepore T, Sikand VK, et al. Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med. 2000;343:1454-1458.
3. Baggish AL, Hill DR. Antiparasitic agent atovaquone. Antimicrob Agents Chemother. 2002;46:1163-1173.
4. McCracken GH Jr. Microbiologic activity of the newer macrolide antibiotics. Pediatr Infect Dis J. 1997;16:432-437.
5. Dobroszycki J, Herwaldt BL, Boctor F, et al. A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor. JAMA. 1999;281:927-930.
6. Homer MJ, guilar-Delfin I, Telford SR III, Krause PJ, Persing DH. Babesiosis. Clin Microbiol Rev. 2000;13:451-469.
7. Krause PJ, McKay K, Gadbaw J, et al. Increasing health burden of human babesiosis in endemic sites. Am J Trop Med Hyg. 2003;68:431-436.
8. Herwaldt BL, Kjemtrup AM, Conrad PA, et al. Transfusion-transmitted babesiosis in Washington State: First reported case caused by a WA1-type parasite. J Infect Dis. 1997;175:1259-1262.
9. McQuiston JH, Childs JE, Chamberland ME, Tabor E. Transmission of tick-borne agents of disease by blood transfusion: A review of known and potential risks in the United States. Transfusion. 2000;40:274-284.
10. Fox LM, Wingerter S, Ahmed A, et al. Neonatal babesiosis: Case report and review of the literature. Pediatr Infect Dis J. 2006;25:169-173.
11. Krause PJ, Spielman A, Telford SR III, et al. Persistent parasitemia after acute babesiosis. N Engl J Med. 1998;339:160-165.
12. Gerber MA, Shapiro ED, Krause PJ, Cable RG, Badon SJ, Ryan RW. The risk of acquiring Lyme disease or babesiosis from a blood transfusion. J Infect Dis. 1994;170:231-234.
13. Leiby DA. Babesiosis and blood transfusion: Flying under the radar. Vox Sang. 2006;90:157-165.
14. Krause PJ, Telford SR III, Pollack RJ, et al. Babesiosis: An underdiagnosed disease of children. Pediatrics. 1992;89:1045-1048.
15. Bregani ER, Tien TV, Cabibbe M, Figini G, Manenti F. Holter monitoring in children with severe Plasmodium falciparum malaria during i. v. quinine treatment. J Trop Pediatr. 2004;50:61.
16. Wittner M, Lederman J, Tanowitz HB, Rosenbaum GS, Weiss LM. Atovaquone in the treatment of Babesia microti infections in hamsters. Am J Trop Med Hyg. 1996;55:219-222.